Skip to content

Jürgen Gallinat

3 papers in the library · 279 citations · publishing 2015-2026

Papers

Sort Most recent Most cited

Informing the redesign of psychiatric seclusion rooms: a mixed-methods pre-evaluation with individuals with lived experience.

BMC Psychiatry January 16, 2026 Leonie Ascone, Candelaria Mahlke, Nour Tawil et al. 2 citations

In acute psychiatric inpatient settings, where perception is altered and emotional vulnerability is heightened, many facilities use coercive seclusion rooms for safety. This practice has been increasingly criticized for its psychological impact. While architectural guidelines emphasize human-centered and biophilic design to support well-being, empirical evidence on how design features in this...

Psychotherapie mit adjuvanter Gabe von serotonergen psychoaktiven Substanzen – Möglichkeiten und Hindernisse

Fortschritte der Neurologie · Psychiatrie July 1, 2017 Tomislav Majić, Henrik Jungaberle, Timo Torsten Schmidt et al. 10 citations

Zusammenfassung Hintergrund Der Einsatz von serotonergen Halluzinogenen (Psychedelika) wie Lysergsäure-Diethylamid (LSD) und Psilocybin und Entaktogenen wie 3,4-Methylendioxymethamphetamin (MDMA) im Rahmen von Psychotherapie ist in den letzten Jahren wieder zunehmend ins Licht des wissenschaftlichen Interesses gerückt. Die vorliegende Arbeit fasst die aktuelle Evidenz zur substanzunterstützten...

Peak experiences and the afterglow phenomenon: When and how do therapeutic effects of hallucinogens depend on psychedelic experiences?

Journal of Psychopharmacology February 9, 2015 Tomislav Majić, Timo T Schmidt, Jürgen Gallinat 267 citations

Interest in the therapeutic potential of psychedelic substances has recently resumed. During an early phase of human psychedelic research, their therapeutic application in different pathologies had been suggested, and the first evidence for efficacy was provided. The range of recent clinical applications of psychedelics spans from cluster headaches and obsessive-compulsive disorder to addiction...